MenuMENU
Meetings & Events > Past ACMT Courses > Clandestine Meth Labs Courses > 2014 Oklahoma City OK

Environmental and Health Consequences of Clandestine Methamphetamine Laboratories

The course is being presented by the American College of Medical Toxicology (ACMT), through an Inter Agency Agreement with Indian Health Services (IHS) and Agency for Toxic Substances and Disease Registry (ATSDR).

Wednesday, April 9, 2014
Oklahoma City Area Indian Health Service
Redbud Conference Room
701 Market Drive
Oklahoma City, OK 73114
9:00 AM – 4:00 PM

*** Registration is free and must be completed by March 9, 2014 ***

Register Here

MethLabExterior

Space is limited, please register early!

Course Description:

This course offers a unique opportunity to learn about the clinical health effects of methamphetamine use and abuse, the hazards of synthesis, health effects of methamphetamines, and clean up and remediation of clandestine laboratories. Children's health and exposure considerations will also be presented. 

The ACMT faculty members are board certified and fellowship trained physician medical toxicologists. They have extensive experience directly caring for patients suffering from the ill effects of chemical agents and poisons. For more information about ACMT please visit their web-site at http://www.acmt.net/index.html.

Target Audience:

The audience will include law enforcement, emergency physicians and medical technicians, public health and environmental professionals, social services providers, HAZMAT professionals, first responders, public policy professionals and others who may work on issues related to clandestine methamphetamine laboratories.

Topics:

1. Clandestine Methamphetamine Laboratories: What are the Issues?

2. Methamphetamine Neurotoxicity.

3. Chemical Hazards of Meth Lab Seizures: Managing Patients Brought from the Scene

4. Evaluation of the Most Vulnerable Population: Children Exposed to Methamphetamine.

5. Protection and Monitoring of Personnel Involved in Laboratory Seizure and Clean-Up.

6. Field Detection and Environmental Consequences of Clandestine Laboratory Clean Up.

7. Tribal Law Enforcement Perspectives.

8. Treatment of Patients with Methamphetamine Addiction.

 

Learning Objectives:

1. Describe the state of methamphetamine use and clandestine meth laboratories in the US.

2. Identify the clinical effects of meth and describe the management of acute and chronic toxicity.

3. Describe the law enforcement perspective on methamphetamine in the community.

4. Describe the chemical hazards of methamphetamine synthesis.

5. Identify personal and environmental protection equipment to be used by first responders.

6. Identify the modalities available to treat victims of the clandestine meth lab exposure.

7. Identify the occupational monitoring requirements for responders.

8. Identify the special features to be considered for the evaluation of children found at the scene.

 

Agenda
8:00-9:00am Registration
9:00-9:30am
Opening Remarks and Welcome
Kurt C. Kleinschmidt, MD, FACMT, University of Texas Southwestern, Dallas, TX
Libby Vianu, Agency for Toxic Substances and Disease Registry, San Francisco, CA 
9:30-10:15am
History and Epidemiology
Evan S. Schwarz, MD, Washington University, St. Louis, MO
10:15-10:30am Break
10:30-11:15am Chemistry of Meth Labs
Kurt C. Kleinschmidt, MD, FACMT, University of Texas Southwestern, Dallas, TX
11:15-12:00pm Medical Effects & Consequences
Amy Young, MD, University of Texas Southwestern, Dallas, TX
12:00-1:00pm Lunch Break
1:00-1:30pm Hazards and PPE
Amy Young, MD
1:30-2:00pm Pediatric Considertions
Evan S. Schwarz, MD
2:00-2:15pm
Break
2:15-2:45pm Bath Salts
Kurt C. Kleinschmidt, MD, FACMT
2:45-3:30pm Tabletop Excercise and Open Discussion
Faculty
3:30-4:00pm Evaluation and Conclusion
 

Funding for this web-based learning module was made possible (in part) by the cooperative agreement award number 4 U61/TS000117-04 from the Agency for Toxic Substances and Disease Registry (ATSDR). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Other information:
Government issued ID required for entry, for federal employee please utilize PIV card.For additional information or questions, please contact, CAPT Richard Turner at IHS: (405) 255-7618, , or Libby Vianu at ATSDR: (415) 947-4319, .